FDA reviewing Vytorin cholesterol drug

Feeling confident about diet drugs and diet surgery, which are useless, unnecessary and dangerous?

"U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.

The Food and Drug Administration said it had not yet received a final report on the study, called Enhance. The agency's review of Vytorin will take about six months after final results are received, the FDA said...

'For a clear picture, we will need to wait for outcomes data (data on heart attack and stroke risk) from larger Vytorin trials' due by 2010 or 2011, Mehta said."

Don't hold your breath or your stomach in.

"The drugmakers have been criticized by doctors, industry analysts and lawmakers for delaying presentation of results from the trial, which was concluded in 2006, until last week.

'The delay has made everyone uncomfortable,' Mehta said. 'We don't know why they didn't come out earlier and just say ... the trial was not showing any possible benefit' in cutting plaque."

"We don't know why they didn't come out earlier?"

How stupid are you?

Money mehtas, Mehta.

And for us, the sick care system should be avoided until absolutely necessary.

Especially for fat care since intervention is almost never needed and it will be years until all the damage from the malpractice of fat treatments will be known.